Article
Alpha2-macroglobulin deletion polymorphism and plasma levels in late onset Alzheimer's disease.
Clinical chemistry and laboratory medicine - 1 Apr 2002
Scacchi Renato, Ruggeri Maria, Gambina Giuseppe, Martini Maria C, Corbo Rosa M
Abstract excerpt
The acute-phase "panproteinase" inhibitor alpha2-macroglobulin (alpha2M), a protein involved in inflammatory reactions, has been identified in amyloid plaques in Alzheimer's disease (AD). In addition, alpha2M is involved in AD susceptibility at the genetic level, and a deletion polymorphism at the a2M gene has been found to be associated with sporadic AD. We analyzed the deletion polymorphism and alpha2M plasma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
